FDA Inspection
3D Imaging Drug Design and DevelopmentFDA Inspection 1228168 - 3D Imaging Drug Design and Development - January 31, 2024
Discuss this record with AI
Record Details
This FDA Inspection record concerns 3D Imaging Drug Design and Development, with an inspection on January 31, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · b62a272a-50d6-4a9e-99be-3d3008f0eb1d
Violation Codes1
21 CFR 314.80(b)
Full citation text and observation details available on the Dashboard.